Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 206-190-3 | CAS number: 306-83-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian germ cell study: cytogenicity / chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: High because a scientifically defensible and guideline method was used. Critical study for SIDS endpoint. Only study summary reviewed from secondary source.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 992
Materials and methods
Test guideline
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- HCFC-123 was evaluated for genotoxic activity in an chromosome aberration study with
peripheral blood lymphocytes from male Sprague-Dawley rats that had been exposed (6 h/d, 7 d/wk) over a period of 14 weeks to HCFC-123 concentrations of 300, 1,000 or 5,000 ppm HCFC-123. Chromosome aberrations were determined in the high dose group. - GLP compliance:
- yes
- Type of assay:
- mammalian germ cell chromosome aberration test
Test material
- Reference substance name:
- 2,2-dichloro-1,1,1-trifluoroethane
- EC Number:
- 206-190-3
- EC Name:
- 2,2-dichloro-1,1,1-trifluoroethane
- Cas Number:
- 306-83-2
- Molecular formula:
- C2HCl2F3
- IUPAC Name:
- 2,2-dichloro-1,1,1-trifluoroethane
- Reference substance name:
- Ethane,2,2-dichloro-1,1,1-trifluoro-
- IUPAC Name:
- Ethane,2,2-dichloro-1,1,1-trifluoro-
- Details on test material:
- - Name of test material (as cited in study report): Ethane,2,2-dichloro-1,1,1-trifluoroethane- HCFC-123
- Purity: not specified
Constituent 1
Constituent 2
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male
Administration / exposure
- Route of administration:
- inhalation
- Details on exposure:
- Male rats (10/exposure level), housed at Huntingdon Research Centre (HRC), were bled following exposure to the test chemical or negative control agent. Blood was taken from each rat and dispensed into a culture tube containing sodium heparin. Tubes were agitated for at least 1 minute, then held at ambient temperature prior to collection, during transportation to Hazelton Microtest, and prior to establishment in culture.
- Duration of treatment / exposure:
- 14 weeks
- Frequency of treatment:
- 6 hours/day, 7 days/week
Doses / concentrations
- Remarks:
- Doses / Concentrations:
0, 300, 1000, 5000 ppm
Basis:
no data
- No. of animals per sex per dose:
- 10 per exposure level
- Control animals:
- yes, concurrent no treatment
- other: positive control 5 rats received a single i.p. injection of 10 ml/kg cyclophosphamide
- Positive control(s):
- A concurrent positive control group of 5 male rats were dosed intraperitoneally with 20 mg/kg cyclophosphamide (CPA) at Hazelton Microtest. These animals were bled 6 hours later on the same day that animals were sampled at HRC.
Examinations
- Tissues and cell types examined:
- Two blood cultures were established for each animal from all treatment and control groups.
- Details of tissue and slide preparation:
- Cultures contained 1 mL of washed blood, Hepes-buffered medium containing fetal calf serum, and gentamycin. Phytohaemagglutinin was included in the culture medium to stimulate the lymphocytes to divide. Cultures were rocked continuously during incubation, and harvested 49 hours following initiation. Colchicine was added 1.5 hours prior to harvest to arrest dividing cells in metaphase. Slides were prepared and stained with Giemsa stain. Fifty metaphases were analyzed per culture for negative and positive control animals and animals receiving 5000 ppm HCFC-123. Mitotic indices based on a total of 500 cells per culture were determined.
- Evaluation criteria:
- The test chemical was considered to be clearly positive if statistically significant increases in the proportion of cells with structural aberrations occurred at 1 (or more) concentration(s). Cells with exchange aberrations or cells with greater than 1 aberration occur very infrequently in negative control cultures. Their appearance was therefore to be considered of biological significance.
Results and discussion
Test results
- Sex:
- male
- Genotoxicity:
- negative
- Toxicity:
- yes
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- When the data from all animals in each group were pooled, fewer cells with aberrations were apparent in the group receiving 5000 ppm HCFC-123 than in the concurrent negative control group. The decrease was small, but statistically significant.
There was no evidence of a reduction in mitotic index in any 5000 ppm HCFC-123-treated animal.
A clear statistically significant increase in cells with aberrations was seen in cultures from rats receiving CPA.
Applicant's summary and conclusion
- Conclusions:
- It is concluded that peripheral blood cultured from animals treated with HCFC 123 at 5000 ppm did not have increased frequencies of lymphocytes with chromosome aberrations when compared with blood from concurrent negative control animals.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.